Case Study: Global Healthcare & Pharmaceutical Company prevents €40M in duplicate payments with apexanalytix firststrike

Healthcare and Pharmaceutical Taking a prevention-based approach to global governance

Global Healthcare & Pharmaceutical Company, a world leader in consumer health, medical devices, diagnostics, biologics, and pharmaceuticals with operations in more than 60 countries, wanted to move from detecting and recovering overpayments after the fact to preventing them upfront. With 250 operating companies worldwide, the company needed stronger global governance to stop payment errors before funds were released to suppliers. apexanalytix was brought in to support this shift, beginning in EMEA, using its firststrike® prevention platform.

apexanalytix implemented firststrike® to analyze pending payments daily, flag potential duplicate payments before disbursement, and help identify fraud risks through the Fraud Detect module. The company also used monthly root cause analysis and best-practice guidance to drive continuous improvement. As a result, apexanalytix helped prevent more than €40 million in duplicate payments, strengthened protection against disbursement fraud, and enabled a more effective data-driven global governance model.